Could you please add e.g. a reference in the README.md of the ADC example or so ... in regard of implementation status for each platform and your plan / schedule to finish it? Example - a chart that ...

DS-9606 was supposed to be the first antibody-drug conjugate in Daiichi Sankyo’s line of anti-cancer assets to use a modified pyrrolobenzodiazepine payload. Daiichi Sankyo has pulled the plug on its ...

Antibody-Drug Conjugates (ADCs) are a core technology in tumor-targeted therapy, featuring a ‘tripartite integrated design’ of ‘precision carrier-stable linker-potent payload’. The carrier component ...

stm32_adc_dma_uart/ ├── src/ │ ├── startup_stm32f401_gcc.s # ARM Cortex-M4 startup code │ ├── system_stm32f4xx.c # System clock initialization (PLL configuration) │ └── main.c # Main firmware (all ...

Enhertu, a targeted cancer therapy from partners AstraZeneca and Daiichi Sankyo, may now be used as a first-line treatment for advanced cases of breast cancer, making it the first new approved ...

Great leadership doesn’t just happen in boardrooms or business settings. From little league coaching and community initiatives to family moments and encounters with service providers, powerful ...

Antibody-drug conjugates (ADCs) are a mature technology. The first ADC, Mylotarg, was initially approved in 2000, and there are now 14 approved agents in both leukemias and solid tumors. According to ...

BEIJING--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based ...

Keeping track of time is essential, even for microcontrollers, which is why a real-time clock (RTC) peripheral is a common feature in MCUs. In the case of the STM32 family there are three varieties of ...

The African Democratic Congress (ADC), a party adopted by the coalition of opposition leaders plotting to sack the ruling All Progressives Congress (APC) in 2027, has failed its first popularity test.

Neutropenia, anemia, and thrombocytopenia are common hematologic toxicities associated with ADCs. The most common cytopenia associated with T-DXd is neutropenia. In the DESTINY-Breast03 trial, ...

As interest in injectable biologics for cancer and other diseases continues to surge, CDMO Simtra BioPharma Solutions is catching the wave stateside with plans for a new commercial manufacturing ...